Latest filing published 03 Jul 2026 for IRLAB Therapeutics AB, €12k.
Insider track record
No signal scores available.
Jan-Fredrik Wilhelm Backman: trading record in brief
Jan-Fredrik Wilhelm Backman discloses dealings in IRLAB Therapeutics AB to Finansinspektionen. Altogether 2 filings, all relating to 3 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 3 July 2026 came the latest disclosure, a transaction for €12k in IRLAB Therapeutics AB. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jan-Fredrik Wilhelm Backman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 112,573 shares@ SEK 1.2067.5% of flowBTA (betald tecknad aktie)ISIN SE0029026145FI:csv-a2fc0dc8407569dc4fe0
- 54,094 shares@ SEK 1.200.023% mcap32.5% of flowAktieISIN SE0012675361FI:csv-38d280ab09db282c0366
2 of 2 declarations